Eugene Zalmover Eugene Zalmover Learn how Eugene’s work paved the way for digital innovation in Patient Safety.
Rafael Sani Simoes Rafael Sani Simoes Learn how Rafael’s role in Patient Safety enables him to make a difference.
CHMP_opinion_nintedanib_ILD_PF CHMP_opinion_nintedanib_ILD_PF Nintedanib received a CHMP positive opinion for the treatment of patients with other chronic fibrosing ILDs with a progressive phenotype beyond IPF
Shimoli Shah Shimoli Shah Watch how Shimoli transitioned from practising clinician to Patient Safety Physician.
Taking cancer on together Taking cancer on together Through their work, our colleagues from around the world hope to empower patients to Take Cancer On.
EC_approval_nintedanib_ILD_PF EC_approval_nintedanib_ILD_PF European Commission approves nintedanib for the treatment of patients with other chronic fibrosing ILDs with a progressive phenotype beyond IPF
Translational Medicine in Immunology Translational Medicine in Immunology Find out how translational medicine is helping bring transformational therapies to patients
Oncology and Cancer Immunology Research Oncology and Cancer Immunology Research Find out more about our research and development in oncology and cancer immunology.
Samina Ajaz Hussain Samina Ajaz Hussain Discover how Samina never looked back on her career move to Patient Safety.
EURORDIS Award EURORDIS Award EURORDIS has selected Boehringer Ingelheim for the first time as recipient of the prestigious Black Pearl Award 2020
Introducing CIAS Introducing CIAS Schizophrenia affects 1 in 100, yet the condition can be misunderstood due to some symptoms being overlooked, such as cognitive impairment
Aservo EquiHaler wins Pharmapack Award 2021 Aservo EquiHaler wins Pharmapack Award 2021 Boehringer Ingelheim’s Aservo® EquiHaler® is recognized in the 2021 Pharmapack Awards